Willis Group Holdings has established a new business unit within Willis Global Markets International (GMI) for the insurance of companies involved in life sciences. Willis has appointed Tom Teixeira as the practice leader, and will focus on major accounts outside the US.

Life sciences industries including biotechnology, pharmaceuticals, chemicals and medical devices are not only faced with the risks of globalization, supply chain liability and litigious operating environments, but they are also exposed to cash flow issues as a result of falling volumes, while trying to mitigate against emerging risks like healthcare reform and intellectual property theft.

Want to continue reading?
Become a Free
PropertyCasualty360 Digital Reader.


  • All PropertyCasualty360.com news coverage, best practices, and in-depth analysis.
  • Educational webcasts, resources from industry leaders, and informative newsletters.
  • Other award-winning websites including BenefitsPRO.com and ThinkAdvisor.com.

Already have an account?



Join PropertyCasualty360

Don’t miss crucial news and insights you need to make informed decisions for your P&C insurance business. Join PropertyCasualty360.com now!

  • Unlimited access to PropertyCasualty360.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including BenefitsPRO.com, ThinkAdvisor.com and Law.com
  • Exclusive discounts on PropertyCasualty360, National Underwriter, Claims and ALM events

Already have an account? Sign In Now
Join PropertyCasualty360

Copyright © 2022 ALM Global, LLC. All Rights Reserved.